MARKET

SMMT

SMMT

Summit Therapeutics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

6.47
-0.09
-1.37%
Closed 16:00 06/23 EDT
OPEN
6.57
PREV CLOSE
6.56
HIGH
6.68
LOW
6.41
VOLUME
151.37K
TURNOVER
--
52 WEEK HIGH
12.30
52 WEEK LOW
2.910
MARKET CAP
629.17M
P/E (TTM)
-8.3754
1D
5D
1M
3M
1Y
5Y
Crestone Joins Antimicrobials Working Group
The Antimicrobials Working Group (AWG) announced today the addition of Crestone, Inc. (Crestone) to its coalition of companies with the mission to combat drug resistant infections and spur life-saving innovations. This new addition brings AWG's membership ...
PR Newswire · 06/08 15:07
Summit Therapeutics to join Russell 3000 Index
Summit Therapeutics (SMMT) to join the broad-market Russell 3000 Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the US markets open on June 28, according to
Seekingalpha · 06/08 11:35
BRIEF-Summit Therapeutics Set To Join Russell 3000 Index
reuters.com · 06/08 11:18
Summit Therapeutics to Be Added to Russell 3000 Index June 28
MT Newswires · 06/08 11:16
Summit Therapeutics set to join Russell 3000(R) Index
Summit Therapeutics Inc. (NASDAQ: SMMT) is set to join the broad-market Russell 3000(R) Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the US markets open on June 28, according to a preliminary list of additions ...
GlobeNewswire · 06/08 11:00
Summit Therapeutics’ Upcoming Annual Shareholders’ Meeting
Cambridge, MA, June 03, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) invites our shareholders and other interested parties to attend our Company’s Annual Shareholders’ Meeting, which will be held virtually on Wednesday, June 16, 2021, a...
GlobeNewswire · 06/03 12:00
BRIEF-Summit Therapeutics Enters Into A Letter Agreement ( Exit Agreement ) With Michael Donaldson, CFO
reuters.com · 05/28 22:31
Summit Therapeutics CFO to Step Down
MT Newswires · 05/28 16:37
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of SMMT. Analyze the recent business situations of Summit Therapeutics through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average SMMT stock price target is 4.500 with a high estimate of 5.00 and a low estimate of 4.000.
EPS
Institutional Holdings
Institutions: 48
Institutional Holdings: 14.51M
% Owned: 14.92%
Shares Outstanding: 97.24M
TypeInstitutionsShares
Increased
16
969.46K
New
9
109.80K
Decreased
8
799.89K
Sold Out
6
112.02K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-0.36%
Pharmaceuticals & Medical Research
-0.51%
Key Executives
Chief Operating Officer
Mahkam Zanganeh
Chief Executive Officer/Executive Director
Glyn Edwards
Chief Operating Officer/Executive Director
Elaine Stracker
Chief Financial Officer
Erik Ostrowski
Non-Executive Independent Director
Rainer Erdtmann
Chief Operating Officer
David Roblin
Other
Ralf Rosskamp
Non-Executive Director
Valerie Andrews
Non-Executive Director
Barry Price
Non-Executive Director
David Wurzer
No Data
About SMMT
Summit Therapeutics Inc. is focused on developing treatments for infectious diseases. The Company uses its Discuva platform, an antibiotic discovery engine to develop antibiotics. It is initially focused on Clostridioides difficile infections (CDI). Its platform is designed to uncover novel bacterial targets and develops new mechanism antibiotics against them. Ridinilazole is its new mechanism antibiotic, which is being developed for CDI.

Webull offers kinds of Summit Therapeutics Inc stock information, including NASDAQ:SMMT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SMMT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SMMT stock methods without spending real money on the virtual paper trading platform.